← Open Payments lookup

ANDREW LEBSON: Open Payments

NPI 1043755952 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$757 in 35 payments from 19 companies in 2025. Trend: 2023 $1,217 · 2024 $981 · 2025 $757

Food & beverage: $757
CompanyPaymentsAmount
Lilly USA, LLC9$190
Novo Nordisk Inc3$69
Amgen Inc.3$58
Radius Health, Inc.2$51
Amneal Pharmaceuticals LLC2$43
Medtronic, Inc.2$40
Neurocrine BioSciences, Inc.1$40
BETA BIONICS, INC.1$35
Insulet Corporation2$34
AstraZeneca Pharmaceuticals LP1$26

Products named: MOUNJARO, JARDIANCE, Tymlos, UNITHROID, TEPEZZA, MINIMED 780G, CRENESSITY, iLet Bionic Pancreas.

Industry payments across MD — which companies pay providers there.